Imagin Medical (CSE:IME; OTCQB:IMEXF; Frankfurt & Stuttgart Symbol:DPD2) will host a virtual investor event with key opinion leaders on Oct. 29 at 12:00 pm ET to highlight the potential of the company’s i/Blue Imaging System.
The webcast event will feature opinion leaders from major academic centers who will share insight into the current state of bladder cancer imaging and the acute need for improved methods to help reduce recurrence and mortality.
“We encourage people to join this informative webcast to learn more about how Imagin is working to address the shortcomings of current bladder cancer imaging technologies, while building a solid product portfolio to support the company’s success,” Jim Hutchens, Imagin’s president and CEO, said in a statement.
The webcast will take place on Oct. 29, 2020 at 12:00 pm ET. A live and archived webcast of the event will be available here.
